HCP Data Innovations

May 2024


The use of data in marketing to physicians by pharmaceutical companies is not a new phenomenon. However, in recent years, there has been a significant increase in the amount of data available (EHR, social, claims, other), which has resulted in more sophisticated sales and marketing tactics to fuel audience building, data analytics, execution, and activation strategies, balanced by an evolving landscape on privacy and the use of cookies.

Marketers recognize the significant benefits of using data in developing sales and marketing strategies for physicians to create highly personalized content and campaigns.

This DHC Group project on HCP Data Innovations uncovers the latest industry thinking on topics including audience building, new and alternative data sources, privacy-first HCP data strategies, and brand execution and activation strategies. Starting with an interactive virtual roundtable with stakeholder discussions, The DHC Group has created an industry position piece, highlighting participant insights and strategies to provide a roadmap for navigating the complexities of the current and future data landscape – ultimately driving better outcomes for patients and healthcare providers.

Industry Report

On May 22, 2024, a roundtable discussion on HCP Data Innovations brought together industry leaders from CMI Media Group, eHealthcare Solutions, Medscape, OptimizeRx, PulsePoint, PurpleLab, and executives from various pharmaceutical and biotech companies. The event addressed the evolving challenges and opportunities in HCP data innovation, emphasizing the transition to a cookieless future, fostering industry collaboration, and integrating advanced technologies like AI and machine learning. This summary synthesizes the key insights and strategies shared during the discussion, highlighting common agreements, necessary actions, and future predictions.

Receive webinar and event announcements delivered to your inbox. Sign up for our newsletter.